Indication
Abnormalities of Pulmonary Vascular Resistance
2 clinical trials
2 products
Clinical trial
Comparison of Intravenous Levosimendan and Inhalational Milrinone in High Risk Cardiac Patients With Pulmonary HypertensionStatus: Recruiting, Estimated PCD: 2023-12-01
Product
LevosimendanProduct
MilrinoneClinical trial
Levosimendan Administration in High Risk Cardiac Surgery Patients With Pulmonary HypertensionStatus: Completed, Estimated PCD: 2022-10-17